| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7464412
[patent_doc_number] => 20040053363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Method for production of a multimeric protein by cell fusion'
[patent_app_type] => new
[patent_app_number] => 10/353844
[patent_app_country] => US
[patent_app_date] => 2003-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12468
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053363.pdf
[firstpage_image] =>[orig_patent_app_number] => 10353844
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/353844 | Method for production of a multimeric protein by cell fusion | Jan 27, 2003 | Abandoned |
Array
(
[id] => 766719
[patent_doc_number] => 07009040
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-07
[patent_title] => 'Cancerous disease modifying antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/348231
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6966
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/009/07009040.pdf
[firstpage_image] =>[orig_patent_app_number] => 10348231
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/348231 | Cancerous disease modifying antibodies | Jan 20, 2003 | Issued |
Array
(
[id] => 6679066
[patent_doc_number] => 20030229207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Modified antibody variable domains'
[patent_app_type] => new
[patent_app_number] => 10/340189
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 24027
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20030229207.pdf
[firstpage_image] =>[orig_patent_app_number] => 10340189
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/340189 | Modified antibody variable domains | Jan 9, 2003 | Abandoned |
Array
(
[id] => 6739689
[patent_doc_number] => 20030157058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Troponin anti-metastatic therapeutic and method of use'
[patent_app_type] => new
[patent_app_number] => 10/337461
[patent_app_country] => US
[patent_app_date] => 2003-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3216
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157058.pdf
[firstpage_image] =>[orig_patent_app_number] => 10337461
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/337461 | Troponin anti-metastatic therapeutic and method of use | Jan 6, 2003 | Abandoned |
Array
(
[id] => 7379902
[patent_doc_number] => 20040220388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Novel heterodimeric fusion proteins'
[patent_app_type] => new
[patent_app_number] => 10/312923
[patent_app_country] => US
[patent_app_date] => 2002-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8519
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20040220388.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312923
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312923 | Novel heterodimeric fusion proteins | Dec 26, 2002 | Abandoned |
Array
(
[id] => 697927
[patent_doc_number] => 07067131
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => 'Methods for using anti-MUC18 antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/330530
[patent_app_country] => US
[patent_app_date] => 2002-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 36
[patent_no_of_words] => 14952
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067131.pdf
[firstpage_image] =>[orig_patent_app_number] => 10330530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/330530 | Methods for using anti-MUC18 antibodies | Dec 25, 2002 | Issued |
Array
(
[id] => 985630
[patent_doc_number] => 06924360
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-02
[patent_title] => 'Antibodies against the MUC18 antigen'
[patent_app_type] => utility
[patent_app_number] => 10/330613
[patent_app_country] => US
[patent_app_date] => 2002-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 35
[patent_no_of_words] => 14313
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/924/06924360.pdf
[firstpage_image] =>[orig_patent_app_number] => 10330613
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/330613 | Antibodies against the MUC18 antigen | Dec 25, 2002 | Issued |
Array
(
[id] => 435636
[patent_doc_number] => 07261890
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-28
[patent_title] => 'Methods for using canine immunoglobulin variable domains and caninized antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/327598
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 10
[patent_no_of_words] => 41125
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/261/07261890.pdf
[firstpage_image] =>[orig_patent_app_number] => 10327598
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/327598 | Methods for using canine immunoglobulin variable domains and caninized antibodies | Dec 19, 2002 | Issued |
Array
(
[id] => 6824956
[patent_doc_number] => 20030235578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-25
[patent_title] => 'Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria'
[patent_app_type] => new
[patent_app_number] => 10/323927
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 21512
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20030235578.pdf
[firstpage_image] =>[orig_patent_app_number] => 10323927
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/323927 | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria | Dec 19, 2002 | Issued |
Array
(
[id] => 6843116
[patent_doc_number] => 20030148463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Novel method for the production of anti-human antigen receptors and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/325694
[patent_app_country] => US
[patent_app_date] => 2002-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 13714
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20030148463.pdf
[firstpage_image] =>[orig_patent_app_number] => 10325694
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/325694 | Novel method for the production of anti-human antigen receptors and uses thereof | Dec 18, 2002 | Abandoned |
Array
(
[id] => 7403321
[patent_doc_number] => 20040023870
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-05
[patent_title] => 'Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins'
[patent_app_type] => new
[patent_app_number] => 10/327491
[patent_app_country] => US
[patent_app_date] => 2002-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 25156
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20040023870.pdf
[firstpage_image] =>[orig_patent_app_number] => 10327491
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/327491 | Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins | Dec 18, 2002 | Abandoned |
Array
(
[id] => 5770716
[patent_doc_number] => 20050266519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Methods and compositions for modulating and detecting activin dimer and dimer formation'
[patent_app_type] => utility
[patent_app_number] => 10/318283
[patent_app_country] => US
[patent_app_date] => 2002-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 29259
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10318283
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/318283 | Methods and compositions for modulating and detecting activin dimer and dimer formation | Dec 11, 2002 | Abandoned |
| 60/509072 | Butyrylcholinesterase variants that alter the activity of chemotherapeutic agents | Dec 3, 2002 | Pending |
Array
(
[id] => 6706309
[patent_doc_number] => 20030153043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Method for the production of non-immunogenic proteins'
[patent_app_type] => new
[patent_app_number] => 10/300215
[patent_app_country] => US
[patent_app_date] => 2002-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 11783
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20030153043.pdf
[firstpage_image] =>[orig_patent_app_number] => 10300215
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/300215 | Method for rendering streptokinase less immunogenic to a human | Nov 19, 2002 | Issued |
Array
(
[id] => 7176097
[patent_doc_number] => 20050123536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Treatment of immunological disorders using anti-dc30 antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/496628
[patent_app_country] => US
[patent_app_date] => 2002-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 46314
[patent_no_of_claims] => 210
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123536.pdf
[firstpage_image] =>[orig_patent_app_number] => 10496628
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/496628 | Treatment of immunological disorders using anti-dc30 antibodies | Nov 19, 2002 | Abandoned |
Array
(
[id] => 6865072
[patent_doc_number] => 20030190598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Single-domain antigen-binding antibody fragments derived from llama antibodies'
[patent_app_type] => new
[patent_app_number] => 10/031874
[patent_app_country] => US
[patent_app_date] => 2002-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11651
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190598.pdf
[firstpage_image] =>[orig_patent_app_number] => 10031874
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/031874 | Single-domain antigen-binding antibody fragments derived from llama antibodies | Nov 13, 2002 | Abandoned |
| 10/293391 | MUC1 interference RNA compositions and methods derived therefrom | Nov 12, 2002 | Abandoned |
Array
(
[id] => 6683883
[patent_doc_number] => 20030119747
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Methods of using pharmaceutical compositions comprising troponin subunits and homologs thereof before, during, or after surgical resection or radiologic ablation of a solid tumor'
[patent_app_type] => new
[patent_app_number] => 10/286134
[patent_app_country] => US
[patent_app_date] => 2002-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 19429
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119747.pdf
[firstpage_image] =>[orig_patent_app_number] => 10286134
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/286134 | Methods of using pharmaceutical compositions comprising troponin subunits and homologs thereof before, during, or after surgical resection or radiologic ablation of a solid tumor | Oct 31, 2002 | Abandoned |
Array
(
[id] => 6739721
[patent_doc_number] => 20030157090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Stabilizing peptides, polypeptides and antibodies which include them'
[patent_app_type] => new
[patent_app_number] => 10/169351
[patent_app_country] => US
[patent_app_date] => 2002-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11588
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157090.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169351
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169351 | Stabilizing peptides, polypeptides and antibodies which include them | Oct 28, 2002 | Abandoned |
Array
(
[id] => 6659208
[patent_doc_number] => 20030134343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Specific mucin expression as a marker for pancreatic cancer'
[patent_app_type] => new
[patent_app_number] => 10/279454
[patent_app_country] => US
[patent_app_date] => 2002-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12448
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10279454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/279454 | MUCIN 4 expression as a marker for pancreatic cancer | Oct 23, 2002 | Issued |